Combined FV and FVIII deficiency (F5F8D) is a rare autosomal recessive bleeding disorder caused by mutations in LMAN1 and MCFD2. Six different causative homozygous mutations (five in LMAN1 and one in MCFD2) were identified in 6 patients with F5F8D. Thrombin generation assay, triggered with 1 pM TF in F5F8D plasma, paradoxically exhibited enhanced thrombin generation compared to normal plasma. A significantly lower free tissue factor pathway inhibitor (fTFPI) was found in F5F8D patients compared to healthy controls (P<0.01). Normalizing TFPIα in F5F8D plasma greatly delayed and reduced thrombin generation. Increasing FV concentrations by adding plasma FV in F5F8D plasma only caused a gradual decrease of thrombin generation, suggesting that low levels of both TFPIα and FV co-contributed to the elevated thrombin generation by reducing their anticoagulant effects. On the contrary, thrombin generation in F5F8D platelet rich plasma (PRP) was significantly lower than in normal controls (P<0.05), but was fully corrected by either normalizing FVIII or after DDAVP infusion, indicating that the hypocoagulable state of F5F8D patients is associated with low FVIII levels. In addition, plasma and platelet FV in F5F8D PRP was sufficient to support normal thrombin generation and low TFPIα may have no effect on thrombin generation. The DDAVP infusion induced a complete response in five F5F8D patients and a partial response in the remaining one. Based on our findings, we suggest that DDAVP may be considered as a potential substitute for FVIII concentrates and FFP infusion may not be necessary for F5F8D patients with minor bleeding challenges. Key Points Low FV accompanied by a low fTFPI in F5F8D has optimal procoagulant activity, and addition of FV to plasma only results in anticoagulation. The use of DDAVP as a potential substitute for FVIII concentrates without FFP infusion is suggested in F5F8D patients with minor bleeding.
Haemophilia A (HA) is a common X-linked recessive bleeding disorder and almost one half of patients with severe HA are caused by intron 22 inversion (Inv22) in the F8. Inv22 is considered to be almost exclusively of meiotic origin in germ cells during spermatogenesis and only one mosaic Inv22 female carrier with the mutation possibly occurring during mitosis of the embryo has been reported so far. Previously we have identified a novel complex recombination mediated by int22h copies in a sporadic severe HA pedigree and herein we have localised the sequences flanking the breakpoint region using genome walking technique, AccuCopy technique, gene chip and real-time PCR. The disease causing genetic variant registered an 18.1 kb deletion including part of int22h-1 through the intron 23 of F8 and a 113.3 kb duplication of part of int22h-2 through the intron 1 of TMLHE inserted in the religated region of the F8. Two intrinsically linked mechanisms of recombination-dependent DNA replication: microhomology-mediated break-induced replication (MMBIR) followed by break-induced replication (BIR) might be responsible for the incident of the complex recombination during early embryogenesis of the proband’s mother. Supplementary Material to this article is available online at www.thrombosis-online.com.
4 January 2024 in Journal of Thrombosis and Haemostasis